Marine Peptides and Proteins with Cytotoxic and Antitumoral Properties
João Varela
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorCatarina Vizetto-Duarte
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorLuísa Custódio
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorLuísa Barreira
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorFernando Albericio
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Institute for Research in Biomedicine, Barcelona, Spain; CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Barcelona, Spain
University of Barcelona, Department of Organic Chemistry, Barcelona, Spain
Search for more papers by this authorJoão Varela
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorCatarina Vizetto-Duarte
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorLuísa Custódio
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorLuísa Barreira
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Search for more papers by this authorFernando Albericio
Centre of Marine Sciences, University of Algarve, Faro, Portugal
Institute for Research in Biomedicine, Barcelona, Spain; CIBER-BBN, Networking Centre on Bioengineering, Biomaterials and Nanomedicine, Barcelona, Spain
University of Barcelona, Department of Organic Chemistry, Barcelona, Spain
Search for more papers by this authorSe-Kwon Kim
Marine Bioprocess Research Center, Pukyong National University, Busan, Republic of Korea
Department of Chemistry, Pukyoung National University, Nam-Gu, Busan, Republic of Korea
Search for more papers by this authorSummary
The wealth of knowledge concerning (poly)peptides with cytotoxic and antitumoral activities that has been gathered in the last 3 decades is astounding. Approval of novel marine peptides for the treatment of oncological patients is very likely to come in the next few years. So far the isolation of marine peptides has had a very limited range of biological sources, but there is a current trend toward widening this search to other taxa, such as fish and nonphotosynthetic bacteria. Moreover, molecular-biology tools such as metagenomics and single-cell genome amplification may soon provide a better understanding of how bioactive peptides are synthesized in nature. The cloning of complete biosynthetic pathways has revealed that bacteria have developed a way to generate an entire collection of peptides by means of cassettes that encode hypervariable amino acid sequences flanked by more conserved regions, which, in turn, recruit modifying enzymes.
References
- ACS. (2012). Cancer Facts & Figures. American Cancer Society: Atlanta, GA.
- Albertson, D. G., Collins, C., McCormick, F., Gray, J. W. (2003). Chromosome aberrations in solid tumors. Nature Genet., 34, 369–376.
- Alemán, A., Pérez-Santín, E., Bordenave-Juchereau, S., Arnaudin, I., Gómez-Guillén, M. C., Montero, P. (2011). Squid gelatin hydrolysates with antihypertensive, anticancer and antioxidant activity. Food Res. Int., 44, 1044–1051.
- Ali, M. A., Rosati, R., Pettit, G. R., Kalemkerian, G. P. (1998). Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines. Anticancer Res., 18, 1021–1026.
- Anderson, H., Coleman, J., Andersen, R., Roberge, M. (1997). Cytotoxic peptides hemiasterlin, hemiasterlin A and hemiasterlin B induce mitotic arrest and abnormal spindle formation. Cancer Chemother. Pharmacol., 39, 223–226.
- Andrianasolo, E. H., Goeger, D., Gerwick, W. H. (2007). Mitsoamide: a cytotoxic linear lipopeptide from the Madagascar marine cyanobacterium Geitlerinema sp. Pure Appl. Chem., 79, 593–602.
- Araki, T., Matsunaga, S., Fusetani, N. (2005). Koshikamide A2, a cytotoxic linear undecapeptide isolated from a marine sponge of Theonella sp. Biosci. Biotechnol. Biochem., 69, 1318–1322.
- Araki, T., Matsunaga, S., Nakao, Y., Furihata, K., West, L., Faulkner, D. J., Fusetani, N. (2008). Koshikamide B, a cytotoxic peptide lactone from a marine sponge Theonella sp. J. Org. Chem., 73, 7889–7894.
- Arnett, S. O., Teillaud, J. L., Wurch, T., Reichert, J. M., Dunlop, C., Huber, M. (2011). IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. 5–9 December 2010, San Diego, CA. MAbs, 3, 133–152.
- Austin, P., Heller, M., Williams, D. E., McIntosh, L. P., Vogl, A. W., Foster, L. J., Andersen, R. J., Roberge, M., Roskelley, C. D. (2010). Release of membrane-bound vesicles and inhibition of tumor cell adhesion by the peptide neopetrosiamide A. PLoS ONE, 5, e10836.
- Bai, R., Pettit, G. R., Hamel, E. (1990). Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem. Pharmacol., 39, 1941–1949.
- Bai, R., Covell, D. G., Liu, C., Ghosh, A. K., Hamel, E. (2002). (−)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly. J. Biol. Chem., 277, 32165–32171.
- Bai, R., Edler, M. C., Bonate, P. L., Copeland, T. D., Pettit, G. R., Ludueña, R. F., Hamel, E. (2009). Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity. Mol. Pharmacol., 75, 218–226.
- Bailly, C. (2009). Ready for a comeback of natural products in oncology. Biochem. Pharmacol., 77, 1447–1457.
- Barboza, N. M., Medina, D. J., Budak-Alpdogan, T., Aracil, M., Jimeno, J. M., Bertino, J. R., Banerjee, D. (2012). Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab. Cancer Biol. Ther., 13, 114–122.
- Belofsky, G. N., Jensen, P. R., Fenical, W. (1999). Sansalvamide: a new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium. Tetrahedron Lett., 40, 2913–2916.
- Berry, J. P., Gantar, M., Gawley, R. E., Wang, M., Rein, K. S. (2004). Pharmacology and toxicology of pahayokolide A, a bioactive metabolite from a freshwater species of Lyngbya isolated from the Florida Everglades. Comp. Biochem. Physiol. C. Toxicol. Pharmacol., 139, 231–238.
- Bonnard, I., Rolland, M., Salmon, J. M., Debiton, E., Barthomeuf, C., Banaigs, B. (2007). Total structure and inhibition of tumor cell proliferation of laxaphycins. J. Med. Chem., 50, 1266–1279.
- Boot, C. M., Tenney, K., Valeriote, F. A., Crews, P. (2006). Highly N-methylated linear peptide produced by an atypical sponge-derived Acremonium sp. J. Nat. Prod., 69, 83–92.
- Braekman, J. C., Daloze, D., Moussiaux, B., Riccio, R. (1987). Jaspamide from the marine sponge Jaspis johnstoni. J. Nat. Prod., 50, 994–995.
- Butler, M. S., Newman, D. J. (2008). Mother Nature's gift to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. Progr. Drug Res., 65, 1–44.
- Carroll, A. R., Feng, Y., Bowden, B. F., Coll, J. C. (1996). Studies of Australian ascidians. 5. Virenamides A-C, new cytotoxic linear peptides from the colonial didemnid ascidian Diplosoma virens. J. Org. Chem., 61, 4059–4061.
- Chevallier, C., Richardson, A. D., Edler, M. C., Hamel, E., Harper, M. K., Ireland, C. M. (2003). A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge Cymbastela sp. Org. Lett., 5, 3737–3739.
- Cho, J. Y., Williams, P. G., Kwon, H. C., Jensen, P. R., Fenical, W. (2007). Lucentamycins A-D, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis. J. Nat. Prod., 70, 1321–1328.
- Chow, A., Arteaga, C. L., Wang, S. E. (2011). When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene. J. Mammary Gland Biol. Neoplasia, 16, 81–88.
- Coleman, J. E., de Silva, E. D., Kong, F., Andersen, R. J. (1995). Cytotoxic peptides from the marine sponge Cymbastela sp. Tetrahedron, 51, 10653–10662.
- Cormier, A., Marchand, M., Ravelli, R. B. G., Knossow, N., Gigant, B. (2008). Structural insight into the inhibition of tubulin by vinca domain peptide ligands. EMBO Rep., 9, 1101–1106.
- Crews, P., Farias, J. J., Emrich, R., Keifer, P. A. (1994). Milnamide A, an unusual cytotoxic tripeptide from the marine sponge Auletta cf. constricta. J. Org. Chem., 59, 2932–2934.
- Cruz-Monserrate, Z., Vervoort, H. C., Bai, R., Newman, D. J., Howell, S. B., Los, G., Mullaney, J. T., Williams, M. D., Pettit, G. R., Fenical, W., Hamel, E. (2003). Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin. Mol. Pharmacol., 63, 1273–1280.
- Davies, M. R., Singh, E. K., Wahyudi, H., Alexander, L. D., Kunicki, J. B., Nazarova, L. A., Fairweather, K. A., Giltrap, A. M., Jolliffe, K. A., McAlpine, S. R. (2012). Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds. Tetrahedron, 68, 1029–1051.
- Davis, R. A., Mangalindan, G. C., Bojo, Z. P., Antemano, R. R., Rodriguez, N. O., Concepcion, G. P., Samson, S. C., de Guzman, D., Cruz, L. J., Tasdemir, D., Harper, M. K., Feng, X., Carter, G. T., Ireland, C. M. (2004). Microcionamides A and B, bioactive peptides from the Philippine sponge Clathria (Thalysias) abietina. J. Org. Chem., 69, 4170–4176.
- Degnan, B. M., Hawkins, C. J., Lavin, M. F., McCaffrey, E. J., Parry, D. L., van den Brenk, A. L., Watters, D. J. (1989). New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella. J. Med. Chem., 32, 1349–1354.
- Dias, N., Vezin, H., Lansiaux, A., Bailly, C. (2005). Topoisomerase inhibitors of marine origin and their potential use as anticancer agents. Top. Curr. Chem., 253, 89–108.
- Donia, M. S., Ravel, J., Schmidt, E. W. (2008). A global assembly line for cyanobactins. Nat. Chem. Biol., 4, 341–343.
- Doronina, S. O., Bovee, T. D., Meyer, D. W., Miyamoto, J. B., Anderson, M. E., Morris-Tilden, C. A., Senter, P. D. (2008). Novel peptide linkers for highly potent antibody-auristatin conjugate. Bioconjugate Chem., 19, 1960–1963.
- Dunlap, W. C., Battershill, C. N., Liprot, C. H., Cobb, R. E., Bourne, D. G., Jaspars, M., Long, P. F., Newman, D. J. (2007). Biomedicinals from the phytosymbionts of marine invertebrates: a molecular approach. Methods, 42, 358–376.
- Edler, M. C., Fernandez, A. M., Lassota, P., Ireland, C. M., Barrows, L. R. (2002). Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10. Biochem. Pharmacol., 63, 707–715.
- Erba, E., Bergamaschi, D., Ronzoni, S., Faretta, M., Taverna, S., Bonfanti, M., Catapano, C. V., Faircloth, G., Jimeno, J., D'Incalci, M. (1999). Mode of action of thiocoraline, a natural marine compound with anti-tumour activity. Br. J. Cancer, 80, 971–980.
-
Fiedler, H. P., Bruntner, C., Riedlinger, J., Bull, A. T., Knutsen, G., Goodfellow, M., Jones, A., Maldonado, L., Pathom-aree, W., Beil, W., Schneider, K., Keller, S., Süssmuth, R. D. (2008). Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J. Antibiot. (Tokyo), 6, 158–163.
10.1038/ja.2008.125 Google Scholar
- Foster, M. P., Concepción, G. P., Caraan, G. B., Ireland, C. M. (1992). Bistramides C and D: two new oxazole-containing cyclic hexapeptides isolated from a Philippine Lissoclinum bistratum Ascidian. J. Org. Chem., 57, 6671–6675.
- Fu, X., Do, T., Schmitz, F. J., Andrusevich, V., Engel, M. H. (1998). New cyclic peptides from the ascidian Lissoclinum patella. J. Nat. Prod., 61, 1547–1551.
- Fusetani, N., Sugawara, T., Matsunaga, S., Hirota, H. (1991). Orbiculamide A: a novel cytotoxic cyclic peptide from a marine sponge Theonella sp. J. Am. Chem. Soc., 113, 7811–7812.
- Gamble, W. R., Durso, N. A., Fuller, R. W., Westergaard, C. K., Johnson, T. R., Sackett, D. L., Hamel, E., Cardellina, J. H., Boyd, M. R. (1999). Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp., Siphonochalina spp. sponges. Bioorg. Med. Chem., 7, 1611–1615.
- Gao, J., Hamann, M. T. (2011). Chemistry and biology of kahalalides. Chem. Rev., 111, 3208–3235.
- Grindberg, R. V., Ishoey, T., Brinza, D., Esquenazi, E., Coates, R. C., Liu, W., Gerwick, L., Dorrestein, P. C., Pevzner, P., Lasken, R., Gerwick, W. H. (2011). Single cell genome amplification accelerates identification of the apratoxin biosynthetic pathway from a complex microbial assemblage. PLoS One, 6, e18565.
- Gulavita, N. K., Gunasekera, S. P., Pomponi, S. A., Robinson, E. V. (1992). Polydiscamide A: a new bioactive depsipeptide from the marine sponge Discodermia sp. J. Org. Chem., 57, 1767–1772.
- Gunasekera, S. P., Ross, C., Paul, V. J., Matthew, S., Luesch, H. (2008). Dragonamides C and D, linear lipopeptides from the marine cyanobacterium brown Lyngbya polychroa. J. Nat. Prod., 71, 887–890.
- Gutiérrez, M., Suyama, T. L., Engene, N., Wingerd, J. S., Matainaho, T., Gerwick, W. H. (2008). Apratoxin D, a potent cytotoxic cyclodepsipeptide from Papua New Guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J. Nat. Prod., 71, 1099–1103.
- Hamada, T., Matsunaga, S., Yano, G., Fusetani, N. (2005). Polytheonamides A and B, highly cytotoxic, linear polypeptides with unprecedented structural features, from the marine sponge, Theonella swinhoei. J. Am. Chem. Soc., 127, 110–118.
- Hamann, M. T., Scheuer, P. J. (1993). Kahalalide F: a bioactive depsipeptide from the sacoglossan mollusk Elysia rufescens and the green alga Bryopsis sp. J. Am. Chem. Soc., 115, 5825–5826.
- Hamann, M. T., Otto, C. S., Scheuer, P. J., Dunbar, D. C. (1996). Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp. J. Org. Chem., 61, 6594–6600.
- Hambley, T. W., Hawkins, C. J., Lavin, M. F., van den Brenk, A., Watters, D. J. (1992). Cycloxazoline: a cytotoxic cyclic hexapeptide from the ascidian Lissoclinum bistratum. Tetrahedron, 48, 341–348.
- Han, B., Goeger, D., Maier, C. S., Gerwick, W. H. (2005). The wewakpeptins, cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J. Org. Chem., 70, 3133–3139.
- Han, B., Gross, H., Goeger, D. E., Mooberry, S. L., Gerwick, W. H. (2006). Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod., 69, 572–575.
- Haustedt, L. O., Mang, C., Siems, K., Schiewe (2006). Rational approaches to natural-product-based drug design. Curr. Opin. Drug Discovery Dev., 9, 445–462.
- Hayakawa, Y., Hattori, Y., Kawasaki, T., Kanoh, K., Adachi, K., Shizuri, Y., Shin-ya, K. (2008). Efrapeptin J, a new down-regulator of the molecular chaperone GRP78 from a marine Tolypocladium sp. J. Antibiot. (Tokyo), 61, 365–371.
- Herrero, A. B., Astudillo, A. M., Balboa, M. A., Cuevas, C., Balsinde, J., Moreno, S. (2008). Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734. Cancer Res., 68, 9779–9787.
- Hsu, K., Li-Chan, E. C. Y., Jao, C. (2011). Antiproliferative activity of peptides prepared from enzymatic hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chem., 126, 617–622.
- Huang, T., Lee, J., Chen, J. (2011). Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT–1080 cells. Mar. Drugs, 9, 1995–2009.
- Ibrahim, S. R. M., Min, C. C., Teuscher, F., Ebel, R., Kakoschke, C., Lin, W., Wray, V., Edrada-Ebel, R., Proksch, P. (2010). Callyaerins A–F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa. Bioorg. Med. Chem., 18, 4947–4956.
- Janmaat, M. L., Rodríguez, J. A., Jimeno, J., Kruyt, F. A. E., Giaccone, G. (2005). Kahalalide F induces necrosis-like death that involves depletion of ErbB3 and inhibition of Akt signalling. Mol. Pharmacol., 68, 502–510.
- Jiang, Y., Ahn, E. Y., Ryu, S. H., Kim, D. K., Park, J. S., Yoon, H. J., You, S., Lee, B. J., Lee, D. S., Jung, J. H. (2004). Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication. BMC Cancer, 4, 70.
- Jiménez, J. I., Scheuer, P. J. (2001). New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod., 64, 200–203.
- Kanoh, K., Matsuo, Y., Adachi, K., Imagawa, H., Nishizawa, M., Shizuri, Y. (2005). Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3–251. J. Antibiot. (Tokyo), 58, 289–292.
- Kimura, M., Wakimoto, T., Egami, Y., Tan, K. C., Ise, Y., Abe, I. (2012). Calyxamides A and B, cytotoxic cyclic peptides from the marine sponge Discodermia calyx. J. Nat. Prod., 75, 290–294.
- Knowles, R. R., Carpenter, J., Blakey, S. B., Kayano, A., Mangion, I. K., Sinz, C. J., MacMillan, D. W. C. (2011). Total synthesis of diazonamide A. Chem. Sci., 2, 308–311.
- Kobayashi, M., Lee, N. K., Shibuya, H., Momose, T., Kitagawa, I. (1991). Marine natural products. XXVI. Biologically active tridecapeptide lactones from the Okinawan marine sponge Theonella swinhoei (Theonellidae). (2). Structures of theonellapeptolides Ia, Ib, Ic, and Ie. Chem. Pharm. Bull. (Tokyo), 39, 1177–1184.
- Kuznetsov, G., TenDyke, K., Towle, M., Cheng, H., Liu, J., Marsh, J. P., Schiller, S. E. R., Spyvee, M. R., Yang, H., Seletsky, B. M., Shaffer, C. J., Marceau, V., Yao, Y., Suh, E. M., Campagna, S., Fang, F. G., Kowalczyk, Littlefield, B. A. (2009). Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin. Mol. Cancer Ther., 8, 2852–2860.
- Kwan, J. C., Rocca, J. R., Abboud, K. A., Paul, V. J., Luesch, H. (2008). Total structure determination of grassypeptolide, a new marine cyanobacterial cytotoxin. Org. Lett., 10, 789–792.
- Li, H., Matsunaga, S., Fusetani, N. (1995). Halicylindramides A-C, antifungal and cytotoxic depsipeptides from the marine sponge Halichondria cylindrata. J. Med. Chem., 38, 338–343.
- Lin, W. J., Chien, Y. L., Pan, C. Y., Lin, T. L., Chen, J. Y., Chiu, S. J., Hui, C. F. (2009). Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptides, 30, 283–290.
- Lin, M., Lin, S., Chen, J., Hui, C., Chen, J. (2010). Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice. Peptides, 31, 1019–1025.
- Ling, Y. H., Aracil, M., Jimeno, J., Perez-Soler, R., Zou, Y. (2009). Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft models. Eur. J. Cancer, 45, 1855–1864.
- Linington, R. G., Edwards, D. J., Shuman, C. F., McPhail, K. L., Matainaho, T., Gerwick, W. H. (2008). Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp. J. Nat. Prod., 71, 22–27.
- Liu, L., Rein, K. S. (2010). New peptides isolated from Lyngbya species: a review. Mar. Drugs, 8, 1817–1837.
- López-Macià, A., Jiménez, J. C., Royo, M., Giralt, E., Albericio, F. (2001). Synthesis and structure determination of kahalalide F (1,2). J. Am. Chem. Soc., 123, 11398–11401.
- Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J., Mooberry, S. L. (2000). Isolation, structure determination, and biological activity of lyngbyabellin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod., 63, 611–615.
- Luesch, H., Moore, R. E., Paul, V. J., Mooberry, S. L., Corbett, T. H. (2001). Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J. Nat. Prod., 64, 907–910.
- Luesch, H., Williams, P. G., Yoshida, W. Y., Moore, R. E., Paul, V. J. (2002). Ulongamides A-F, new beta-amino acid-containing cyclodepsipeptides from Palauan collections of the marine cyanobacterium Lyngbya sp. J. Nat. Prod., 65, 996–1000.
- Marquez, B. L., Watts, K. S., Yokochi, A., Roberts, M. A., Verdier-Pinard, P., Jimenez, J. I., Hamel, E., Scheuer, P. J., Gerwick, W. H. (2002). Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. J. Nat. Prod., 65, 866–871.
- Mateos, M. V., Cibeira, M. T., Richardson, P. G., Prosper, F., Oriol, A., de la Rubia, J., Lahuerta, J. J., García-Sanz, R., Extremera, S., Szyldergemajn, S., Corrado, C., Singer, H., Mitsiades, C. S., Anderson, K. C., Bladé, J., San Miguel, J. (2010). Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma. Clin. Cancer Res., 16, 3260–3269.
- Matsunaga, S., Fusetani, N. (1995). Theonellamides A-E, cytotoxic bicyclic peptides, from a marine sponge Theonella sp. J. Org. Chem., 60, 1177–1181.
- Matsuo, Y., Kanoh, K., Yamori, T., Kasai, H., Katsuta, A., Adachi, K., Shin-Ya, K., Shizuri, Y. (2007). Urukthapelstatin A, a novel cytotoxic substance from marine-derived Mechercharimyces asporophorigenens YM11–542. I. Fermentation, isolation and biological activities. J. Antibiot. (Tokyo), 60, 251–255.
- Mayer, A. M. S., Gustafson, K. R. (2008). Marine pharmacology in 2005–2006: antitumour and cytotoxic compounds. Eur. J. Cancer, 44, 2357–2387.
- Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kern, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., Schuster, D. E. (2010). The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol. Sci., 31, 255–265.
- Mayer, A. M. S. (2012). Marine pharmaceuticals: the clinical pipeline. http://marinepharmacology.midwestern.edu/clinPipeline.htm, last accessed 30 October 2012.
- McPhail, K. L., Correa, J., Linington, R. G., González, J., Ortega-Barría, E., Capson, T. L., Gerwick, W. H. (2007). Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod., 70, 984–988.
- Medina, R. A., Goeger, D. E., Hills, P., Mooberry, S. L., Huang, N., Romero, L. I., Ortega-Barrića, E., Gerwick, W. H., McPhail, K. L. (2008). Coibamide A, a potent antiproliferative cyclic depsipeptide from the panamanian marine cyanobacterium Leptolyngbya sp. J. Am. Chem. Soc., 130, 6324–6325.
- Mevers, E., Liu, W. T., Engene, N., Mohimani, H., Byrum, T., Pevzner, P. A., Dorrestein, P. C., Spadafora, C., Gerwick, W. H. (2011). Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. J. Nat. Prod., 74, 928–936.
- Miller, E. D., Kauffman, C. A., Jensen, P. R., Fenical, W. (2007). Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces. J. Org. Chem., 72, 323–330.
- Molinski, T. F., Dalisay, D. S., Lievens, S. L., Saludes, J. P. (2009). Drug development from marine natural products. Nat. Rev. Drug Discovery, 8, 69–85.
- Morita, K., Koiso, Y., Hashimoto, Y., Kobayashi, M., Wang, W., Ohyabu, N., Iwasaki, S. (1997). Interaction of arenastatin A with porcine brain tubulin. Biol. Pharm. Bull., 20, 171–174.
- Muñoz-Alonso, M. J., González-Santiago, L., Zarich, N., Martínez, T., Alvarez, E., Rojas, J. M., Muñoz, A. (2008). Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells. J. Pharmacol. Exp. Ther., 324, 1093–1101.
- Nakao, Y., Yoshida, S., Matsunaga, S., Shindoh, N., Terada, Y., Nagai, K., Yamashita, J. K., Ganesan, A., van Soest, R. W. M., Fusetani, N. (2006). Azumamides A–E: histone deacetylase inhibitory cyclic tetrapeptides from the marine sponge Mycale izuensis. Angew. Chem. Int. Ed., 45, 7553–7557
- Naumovski, L., Junutula, J. R. (2010). Glembatumumab vedotin, a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer. Curr. Opin. Mol. Ther., 12, 248–57.
- Ning, X., Zhao, J., Zhang, Y., Cao, S., Liu, M., Ling, P., Lin, X. (2009). A novel anti-tumor protein extracted from Meretrix meretrix Linnaeus induces cell death by increasing cell permeability and inhibiting tubulin polymerization. Int. J. Oncol., 35, 805–812.
- Nogle, L. M., Gerwick, W. H. (2002). Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage. Org. Lett., 4, 1095–1098.
- Oflazoglu, E., Stone, I. J., Gordon, K., Wood, C. G., Repasky, E. A., Grewal, I. S., Law, C. L., Gerber, H. P. (2008). Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker. Clin. Cancer Res., 19, 6171–6180.
- Pardhasaradhi, B. V. V., Ali, A. M., Kumari, A. L., Reddanna, P., Khar, A. (2003). Phycocyanin-mediated apoptosis in AK-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS. Mol. Cancer Ther., 2, 1165–1170.
- Pettit, G. R., Kamano, Y., Herald, C. L., Tuinman, A. A., Boettner, F. E., Kizu, H., Schmidt, J. M., Baczynskyj, L., Tomer, K. B., Bontems, R. (1987). The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10. J. Am. Chem. Soc., 109, 6883–6885.
- Pettit, G. R., Cichacz, Z., Barkoczy, J., Dorsaz, A. C., Herald, D. L., Williams, M. D., Doubek, D. L., Schmidt, J. M., Tackett, L. P., Brune, D. C., Cerny, R., Hooper, J. N. A., Tackett, L. P., Bakus, G. J. (1993). Isolation and structure of the marine sponge cell growth inhibitory cyclic peptide phakellistatin 1. J. Nat. Prod., 56, 260–267.
- Pettit, G. R., Gao, F., Cerny, R. L., Doubek, D. L., Tackett, L. P., Schmidt, J. M., Chapuis, J.-C. (1994). Antineoplastic agents. 278. Isolation and structure of axinastatins 2 and 3 from a Western Caroline island marine sponge. J. Med. Chem., 37, 1165–1168.
- Pitot, H. C., McElroy, E. A. Jr, Reid, J. M., Windebank, A. J., Sloan, J. A., Erlichman, C., Bagniewski, P. G., Walker, D. L., Rubin, J., Goldberg, R. M., Adjei, A. A., Ames, M. M. (1999). Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors. Clin. Cancer Res., 5, 525–531.
- Plaza, A., Bifulco, G., Keffer, J. L., Lloyd, J. R., Baker, H. L., Bewley, C. A. (2009). Celebesides A-C and Theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J. Org. Chem., 74, 504–512.
- Qureshi, A., Colin, P. L., Faulkner, D. J. (2000). Microsclerodermins F–I, antitumor and antifungal cyclic peptides from the lithistid sponge Microscleroderma sp. Tetrahedron, 56, 3679–3685.
- Radjasa, O. K., Vaske, Y. M., Navarro, G., Vervoort, H. C., X., Tenney, K., Linington, R. G., Crews, P. (2011). Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants. Bioorg. Med. Chem., 19, 6658–6674.
- Ratnayake, A. S., Bugni, T. S., Feng, X., Harper, M. K., Skalicky, J. J., Mohammed, K. A., Andjelic, C. D., Barrows, L. R., Ireland, C. M. (2006). Theopapuamide: a cyclic depsipeptide from a Papua New Guinea lithistid sponge Theonella swinhoei. J. Nat. Prod., 69, 1582–1586.
- Rashid, M. A., Gustafson, K. R., Boswell, J. L., Boyd, M. R. (2000). Haligramides A and B, two new cytotoxic hexapeptides from the marine sponge Haliclona nigra. J. Nat. Prod., 63, 956–959.
- Rinehart, K. Jr, Gloer, J., Hughes, R. Jr, Renis, H., McGovren, J., Swynenberg, E., Stringfellow, D., Kuentzel, S., Li, L. (1981). Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate. Science, 212, 933–935.
- Rinehart, K., Gloer, J., Cook, J., Carter Jr, Mizsak, S., Scahill, T. (1987). Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate. J. Am. Chem. Soc., 103, 1857–1859.
- Rocha-Lima, C. M., Bayraktar, S., MacIntyre, J., Raez, L., Flores, A. M., Ferrell, A., Rubin, E. H., Poplin, E. A., Tan, A. R., Lucarelli, A., Zojwalla, N. (2012). A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors. Cancer, doi:10.1002/cncr.27428.
- Ryu, G., Matsunaga, S., Fusetani, N. (1994a). Discodermins E, a cytotoxic and antimicrobial tetradecapeptide from the marine sponge Discodermia kiiensis. Tetrahedron Lett, 35, 8251–8254.
- Ryu, G., Matsunaga, S., Fusetani, N. (1994b). Discodermins F-H, cytotoxic and antimicrobial tetradecapeptides from the marine sponge Discodermia kiiensis: structure revision of Discodermins A-D. Tetrahedron, 50, 13409–13416.
- Sadar, M. D., Williams, D. E., Mawji, N. R., Patrick, B. O., Wikanta, T., Chasanah, E., Irianto, H. E., Soest, R. V., Andersen, R. J. (2008). Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells. Org. Lett., 10, 4947–4950.
- Sakai, R., Rinehart, K. L., Kishore, V., Kundu, B., Faircloth, G., Gloer, J. B., Carney, J. R., Namikoshi, M., Sun, F., Hughes, R. G. Jr, Grávalos, D. G., de Quesada, T. G., Wilson, G. R., Heid, R. M. (1996). Structure-activity of the didemnins. J. Med. Chem., 39, 2819–2834.
- Schmidt, E. W., Raventos-Suarez, C., Bifano, M., Menendez, A. T., Fairchild, C. R., Faulkner, D. J. (2004). Scleritodermin A, a cytotoxic cyclic peptide from the Lithistid sponge Scleritoderma nodosum. J. Nat. Prod., 67, 475–478.
- Schmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., Ravel, J. (2005). Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. Acad. Sci. USA, 102, 7315–7320.
- Schneider, K., Keller, S., Wolter, F. E., Röglin, L., Beil, W., Seitz, O., Nicholson, G., Bruntner, C., Riedlinger, J., Fiedler, H.-P., Süssmuth, R. D. (2008). Proximicins A, B, and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora induce upregulation of p53 and the Cyclin Kinase Inhibitor p21. Angew. Chem. Int., 47, 3258–3261.
- Schöffski, P., Thate, B., Beutel, G., Bolte, O., Otto, D., Hofmann, M., Ganser, A., Jenner, A., Cheverton, P., Wanders, J., Oguma, T., Atsumi, R., Satomi, M. (2004). Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer. Ann. Oncol., 15, 671–679.
- Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., Gerwick, W. H. (2005). Marine natural products as anticancer drugs. Mol. Cancer Ther., 4, 333–342.
- Simmons, T. L., McPhail, K. L., Ortega-Barría, E., Mooberry, S. L., Gerwick, W. H. (2006). Belamide A, a new antimitotic tetrapeptide from a Panamanian marine cyanobacterium. Tetrahedron Lett., 47, 3387–3390.
- Simmons, T. L., Nogle, L. M., Media, J., Valeriote, F. A., Mooberry, S. L., Gerwick, W. H. (2009). Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. J. Nat. Prod., 72, 1011–1016.
- Sivonen, K., Leikoski, N., Fewer, D., Jokela, J. (2010). Cyanobactins—ribosomal cyclic peptides produced by cyanobacteria. Appl. Microbiol. Biotechnol., 86, 1213–1225.
- Soares, D. G., Escargueil, A. E., Poindessous, V., Sarasin, A., de Gramont, A., Bonatto, D., Henriques, J. A. P., Larsen, A. K. (2007). Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. Proc. Natl. Acad. Sci. USA, 104, 13062–13067.
- Somboonwiwat, K., Marcos, M., Tassanakajon, A., Klinbunga, S., Aumelas, A., Romestand, B., Gueguen, Y., Boze, H., Moulin, G., Bachère, E. (2005). Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon. Dev. Comp. Immunol., 29, 841–851.
- Sonnenschein, R. N., Farias, J. J., Tenney, K., Mooberry, S. L., Lobkovsky, E., Clardy, J., Crews, P. (2004). A further study of the cytotoxic constituents of a milnamide-producing sponge. Org. Lett., 6, 779–782.
- Subhashini, J., Mahipal, S. V., Reddy, M. C., Reddy, M. M., Rachamallu, A., Reddanna, P. (2004). Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. Biochem. Pharmacol., 68, 453–462.
- Tabudravu, J., Morris, L. A., Kettenes-van den Bosch, J. J., Jaspars, M. (2001). Wainunuamide, a histidine-containing proline-rich cyclic heptapeptide isolated from the Fijian marine sponge Stylotella aurantium. Tetrahedron Lett., 42, 9273–9276.
- Takada, Y., Umehara, M., Katsumata, R., Nakao, Y., Kimura, J. (2012). The total synthesis and structure-activity relationships of a highly cytotoxic depsipeptide kulokekahilide-2 and its analogs. Tetrahedron, 68, 659–669.
- Talpir, R., Benayahu, Y., Kashman, Y., Pannell, L., Schleyer, M. (1994). Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge Hemiasterella minor (Kirkpatrick). Tetrahedron Lett., 35, 4453–4456.
- Tan, L. T., Sitachitta, N., Gerwick, W. H. (2003). The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod., 66, 764–771.
- Taori, K., Paul, V. J., Luesch, H. (2008). Structure and activity of largazole, a potent antiproliferative agent from the floridian marine cyanobacterium Symploca sp. J. Am. Chem Soc., 130, 1806–1807.
- Taylor, S. W., Craig, A. G., Fischer, W. H., Park, M., Lehrer, R. I. (2000). Styelin D, an extensively modified antimicrobial peptide from ascidian hemocytes. J. Biol. Chem., 275, 38417–38426.
- Teruya, T., Sasaki, H., Fukazawa, H., Suenaga, K. (2009). Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity. Org. Lett., 11, 5062–5065.
- Tidgewell, K., Engene, N., Byrum, T., Media, J., Doi, T., Valeriote, F. A., Gerwick, W. H. (2010). Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. ChemBioChem, 11, 1458–1466.
- Tripathi, A., Puddick, J., Prinsep, M. R., Lee, P. P. F., Tan, L. T. (2009). Hantupeptin A, a cytotoxic cyclic depsipeptide from a Singapore collection of Lyngbya majuscula. J. Nat. Prod., 72, 29–32.
- Tripathi, A., Puddick, J., Prinsep, M. R., Rottmann, M., Chan, K. P., Chen, D. Y., Tan, L. T. (2011). Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula. Phytochem., 72, 2369–2375.
- Udenigwe, C. C., Aluko, R. E. (2012). Food protein-derived bioactive peptides: production, processing and potential health benefits. J. Food Sci., 71, 11–24.
- Ueoka, R., Ise, Y., Ohtsuka, S., Okada, S., Yamori, T., Matsunaga, S. (2010). Yaku'amides A and B, cytotoxic linear peptides rich in dehydroamino acids from the marine sponge Ceratopsion sp. J. Am. Chem. Soc., 132, 17692–17694.
- Urdiales, J. L., Morata, P., de Castro, I. G., Sánchez-Jiménez, F. (1996). Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett., 102, 31–37.
- Vagner, J., Qu, H., Hruby, V. J. (2008). Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol., 12, 292–296.
- Wang, Y., Zhang, F., Zhang, Y., Liu, J. O., Ma, D. (2008). Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues. Bioorg. Med. Chem. Lett., 18, 4385–4387.
- Wang, Y.-K., He, H.-L., Wang, G.-F., Wu, H., Zhou, B.-C., Chen, X.-L., Zhang, Y. Z. (2010). Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Mar. Drugs, 8, 255–268.
- Wesson, K. J., Hamann, M. T. (1996). Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii. J. Nat. Prod., 59, 629–631.
- Williams, A. B., Jacobs, R. S. (1993). A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. Cancer Lett., 71, 97–102.
- Williams, P. G., Yoshida, W. Y., Moore, R. E., Paul, V. J. (2002a). Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp. J. Nat. Prod., 65, 1336–1339.
- Williams, P. G., Yoshida, W. Y., Moore, R. E., Paul, V. J. (2002b). Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides. J. Nat. Prod., 65, 29–31.
- Williams, P. G., Luesch, H., Yoshida, W. Y., Moore, R. E., Paul, V. J. (2003a). Continuing studies on the cyanobacterium Lyngbya sp.: isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D. J. Nat. Prod., 66, 595–598.
- Williams, P. G., Yoshida, W. Y., Quon, M. K., Moore, R. E., Paul, V. J. (2003b). Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp. J. Nat. Prod., 66, 651–654.
- Williams, P. G., Yoshida, W. Y., Moore, R. E., Paul, V. J. (2003c). Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. J. Nat. Prod., 66, 620–624.
- Williams, P. G., Yoshida, W. Y., Quon, M. K., Moore, R. E., Paul, V. J. (2003d). The structure of palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya. J. Nat. Prod., 66, 1545–1549.
- Williams, D. E., Austin, P., Diaz-Marrero, A. R., Soest, R. V., Matainaho, T., Roskelley, C. D., Roberge, M., Andersen, R. J. (2005). Neopetrosiamides, peptides from the marine sponge Neopetrosia sp. that inhibit amoeboid invasion by human tumor cells. Org. Lett., 7, 4173–4176.
- Williams, D. E., Yu, K., Behrisch, H. W., Van Soest, R., Andersen, R. J. (2009). Rolloamides A and B, cytotoxic cyclic heptapeptides isolated from the Caribbean marine sponge Eurypon laughlini. J. Nat. Prod., 72, 1253–1257.
- Winder, P. L., Pomponi, S. A., Wright, A. E. (2011). Natural products from the Lithistida: a review of the literature since 2000. Mar. Drugs, 9, 2643–2682.
- Wosikowski, K., Schuurhuis, D., Johnson, K., Paull, K. D., Myers, T. G., Weinstein, J. N., Bates, S. E. (1997). Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns. J. Natl. Cancer Inst., 89, 1505–1515.
- Wyche, T. P., Hou, Y., Braun, D., Cohen, H. C., Xiong, M. P., Bugni, T. S. (2011). First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. J. Org. Chem., 76, 6542–6547.
- Yu, Z., Lang, G., Kajahn, I., Schmaljohann, R., Imhoff, J. F. (2008). Scopularides A and B, cyclodepsipeptides from a marine sponge-derived fungus, Scopulariopsis brevicaulis. J. Nat. Prod., 71, 1052–1054.
- Yurek-George, A., Cecil, A. R. L., Mo, A. H. K., Wen, S., Rogers, H., Habens, F., Maeda, S., Yoshida, M., Packham, G., Ganesan, A. (2007). The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. J. Med. Chem., 50, 5720–5726.
- Zampella, A., D'Auria, M. V., Paloma, L. G., Casapullo, A., Minale, L., Debitus, C., Henin, Y. (1996). Callipeltin A, an anti-HIV cyclic depsipeptide from the New Caledonian lithistida sponge Callipelta sp. J. Am. Chem. Soc., 118, 6202–6209.
- Zampella, A., Sepe, V., Bellotta, F., Luciano, P., D'Auria, M. V., Cresteil, T., Debitus, C., Petek, S., Poupat, C., Ahond, A. (2009). Homophymines B-E and A1-E1, a family of bioactive cyclodepsipeptides from the sponge Homophymia sp. Org. Biomol. Chem., 7, 4037–4044.
- Zheng, L., Ling, P., Wang, Z., Niu, R., Hu, C., Zhang, T., Lin, X. (2007). A novel polypeptide from shark cartilage with potent anti-angiogenic activity. Cancer Biol. Ther., 6, 775–780.